| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |